| 产品详情 |
| Edit |   |
|---|
| Product Name | B2 |
|---|
| Description | Promotes inclusion formation in cellular models of Huntington's disease and Parkinson's disease. Prevents mutant huntingtin-mediated proteasome dysfunction and reduces α-synuclein-mediated toxicity. Purity 98%. MW (observed): 396.83 |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 5-[4-(4-Chlorobenzoyl)-1-piperazinyl]-8-nitroquinoline. CPNQ |
|---|
| Gene, Accession, CAS # | CAS: 115687-05-3 |
|---|
| Catalog # | 2855/10 |
|---|
| Price | |
|---|
| Order / More Info | B2 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|